New drug for lung cancer progressing
25th Nov 2005, 09:03 GMT
Hycamtim (topotecan powder) has received positive opinion from the CHMP for the treatment of patients with relapsed small cell lung cancer for whom re-treatment with the first-line regimen is not considered appropriate.
New drug for lung cancer progressing related news:
- Q&A with a Lung Cancer Survivor — Science Blog -
- Lung cancer linked to missing protein — The Cancer Blog
- New Clues to Vitamin A Resistance in Lung Cancer Found — iVillage Health & Well-Being News
- Cellular clues to vitamin A resistance in lung cancer — News-Medical News Feed
- Inherited susceptibility to lung cancer may be associated with the T790M drug resistance mutation in EGFR — Nature Genetics
- AstraZeneca starts key study for new cancer drug — Reuters: Shares
- Plant product offers lung cancer hope — HEALTH
- Deguelin, a possible cure for lung cancer: Study — The Earth Times Online Newspaper
- $8.5 million to fund cancer drug development — Professional organisations latest news on Laboratorytalk
- Drug may stem weight loss during radiation treatments — Medical News Today RSS/XML Feed
Latest news from OnMedica Latest News:
- Diagnosis by internet now popular and can work
- Draft NICE guidance on substance misuse available for consultation
- MDU advise on healthcare assitants giving flu vaccinations
- Drinking not recognised as mouth cancer cause
- More confusion over painkillers revealed
- New sexual health campaign for young adults
- NHS financial crisis is squeezing medical education
- World Diabetes Day is today
- NHS patients to choose hospitals through local libraries
- Patient hospital choice system needs improvement